Precigen, Inc. (PGEN)
7.17
-0.03
(-0.42%)
USD |
NASDAQ |
Aug 24, 16:00
7.18
+0.01
(+0.14%)
After-Hours: 20:00
Precigen 1 Year Total Returns (Daily) : 71.53% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 71.53% |
| August 21, 2026 | 97.80% |
| August 20, 2026 | 131.8% |
| August 19, 2026 | 122.4% |
| August 18, 2026 | 128.8% |
| August 17, 2026 | 122.8% |
| August 14, 2026 | 229.7% |
| August 13, 2026 | 239.8% |
| August 12, 2026 | 280.6% |
| August 11, 2026 | 294.3% |
| August 10, 2026 | 293.3% |
| August 07, 2026 | 284.6% |
| August 06, 2026 | 277.6% |
| August 05, 2026 | 257.0% |
| August 04, 2026 | 271.0% |
| August 03, 2026 | 295.8% |
| July 31, 2026 | 266.7% |
| July 30, 2026 | 243.4% |
| July 29, 2026 | 247.1% |
| July 28, 2026 | 250.0% |
| July 27, 2026 | 245.2% |
| July 24, 2026 | 237.5% |
| July 23, 2026 | 233.7% |
| July 22, 2026 | 250.0% |
| July 21, 2026 | 200.0% |
| Date | Value |
|---|---|
| July 20, 2026 | 188.1% |
| July 17, 2026 | 172.0% |
| July 16, 2026 | 169.0% |
| July 15, 2026 | 176.8% |
| July 14, 2026 | 162.6% |
| July 13, 2026 | 182.5% |
| July 10, 2026 | 178.5% |
| July 09, 2026 | 191.1% |
| July 08, 2026 | 227.1% |
| July 07, 2026 | 246.5% |
| July 06, 2026 | 245.7% |
| July 02, 2026 | 250.3% |
| July 01, 2026 | 262.1% |
| June 30, 2026 | 301.4% |
| June 29, 2026 | 316.9% |
| June 26, 2026 | 309.8% |
| June 25, 2026 | 288.7% |
| June 24, 2026 | 260.0% |
| June 23, 2026 | 262.2% |
| June 22, 2026 | 271.0% |
| June 18, 2026 | 223.5% |
| June 17, 2026 | 233.1% |
| June 16, 2026 | 208.4% |
| June 15, 2026 | 215.8% |
| June 12, 2026 | 192.8% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Geron Corp. | 4.11% |
| Elicio Therapeutics, Inc. | -74.75% |
| Agenus, Inc. | 69.69% |
| Amgen, Inc. | 55.28% |
| Anika Therapeutics, Inc. | 121.1% |